共 15 条
[1]
Doherty J(2004)What is next for pharmacoeconomics and outcomes research in Asia? Value Health 7 118-132
[2]
Kamae I(2017)New decision-making processes for the pricing of health technologies in Japan: the FY2016/2017 pilot phase for the introduction of economic evaluations Health Policy 121 836-841
[3]
Lee K(2017)Development of an official guideline for the economic evaluation of drugs/medical devices in Japan Value Health 20 372-378
[4]
Shiroiwa T(2017)A new health technology assessment system for Japan? Simulating the potential impact on the price of simeprevir Int J Technol Assess Health Care 33 121-127
[5]
Fukuda T(undefined)undefined undefined undefined undefined-undefined
[6]
Ikeda S(undefined)undefined undefined undefined undefined-undefined
[7]
Takura T(undefined)undefined undefined undefined undefined-undefined
[8]
Shiroiwa T(undefined)undefined undefined undefined undefined-undefined
[9]
Fukuda T(undefined)undefined undefined undefined undefined-undefined
[10]
Ikeda S(undefined)undefined undefined undefined undefined-undefined